Cargando…
Metformin targets intestinal immune system signaling pathways in a high-fat diet-induced mouse model of obesity and insulin resistance
INTRODUCTION: Research findings of the past decade have highlighted the gut as the main site of action of the oral antihyperglycemic agent metformin despite its pharmacological role in the liver. Extensive evidence supports metformin’s modulatory effect on the composition and function of gut microbi...
Autores principales: | Brīvība, Monta, Silamiķele, Laila, Kalniņa, Ineta, Silamiķelis, Ivars, Birzniece, Līga, Ansone, Laura, Jagare, Lauma, Elbere, Ilze, Kloviņš, Jānis |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10546317/ https://www.ncbi.nlm.nih.gov/pubmed/37795356 http://dx.doi.org/10.3389/fendo.2023.1232143 |
Ejemplares similares
-
Metformin Strongly Affects Gut Microbiome Composition in High-Fat Diet-Induced Type 2 Diabetes Mouse Model of Both Sexes
por: Silamiķele, Laila, et al.
Publicado: (2021) -
Whole-blood transcriptome profiling reveals signatures of metformin and its therapeutic response
por: Ustinova, Monta, et al.
Publicado: (2020) -
Spatial variation of the gut microbiome in response to long-term metformin treatment in high-fat diet-induced type 2 diabetes mouse model of both sexes
por: Silamiķele, Laila, et al.
Publicado: (2023) -
Metformin strongly affects transcriptome of peripheral blood cells in healthy individuals
por: Ustinova, Monta, et al.
Publicado: (2019) -
Baseline gut microbiome composition predicts metformin therapy short-term efficacy in newly diagnosed type 2 diabetes patients
por: Elbere, Ilze, et al.
Publicado: (2020)